Do Devices that Monitor or Zap the Brain Live Up to Their Claims?

Direct-to-consumer neurotechnologies using EEG or tDCS are becoming increasingly popular, but some scientists are concerned about the lack of evidence for efficacy.

Written byDiana Kwon
| 8 min read
eeg tdcs neurowearables neurotechnology meditation depression

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

ABOVE: © ISTOCK.COM, ANDREAOBSEROVA

Direct-to-consumer neurotechnology is all the rage. A quick Google search will reveal devices that promise to accelerate learning, promote weight loss, improve sleep, and treat depression, just to name a few. The number of new patents for brain health technologies, which include both mental health apps and devices that monitor or stimulate the brain, exploded over the last decade—and are now worth billions of dollars.

Dozens of companies are selling wearable neurotechnologies—gadgets that typically work by either recording brainwaves using electroencephalography (EEG) or by stimulating the brain with transcranial direct current stimulation (tDCS). Despite wide-ranging claims about their benefits, many of these devices lack the evidence to back them up, according to a paper published last month (May 22) in Neuron by University of British Columbia neuroethicist Judy Illes and her colleagues.

We don’t have unequivocal scientific evidence that this brain stimulation technique [can] change cognitive ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Diana is a freelance science journalist who covers the life sciences, health, and academic life. She’s a regular contributor to The Scientist and her work has appeared in several other publications, including Scientific American, Knowable, and Quanta. Diana was a former intern at The Scientist and she holds a master’s degree in neuroscience from McGill University. She’s currently based in Berlin, Germany.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies